Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance

BACKGROUND: Prostate Cancer (PCa) is the second most prevalent cancer among U.S. males. In recent decades many men with low risk PCa have been over diagnosed and over treated. Given significant co-morbidities associated with definitive treatments, maximizing patient quality of life while recognizing...

Descripción completa

Detalles Bibliográficos
Autores principales: Pestova, Katerina, Koch, Adam J., Quesenberry, Charles P., Shan, Jun, Zhang, Ying, Leimpeter, Amethyst D., Blondin, Beth, Sitailo, Svetlana, Buckingham, Lela, Du, Jing, Fei, Huixin, Van Den Eeden, Stephen K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749018/
https://www.ncbi.nlm.nih.gov/pubmed/29291731
http://dx.doi.org/10.1186/s12885-017-3910-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749018/
https://www.ncbi.nlm.nih.gov/pubmed/29291731
http://dx.doi.org/10.1186/s12885-017-3910-4

Ejemplares similares